 Jon Blevins
Concepts (198)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Borrelia burgdorferi | 20 | 2024 | 31 | 5.700 |
Why?
| | Bacterial Proteins | 26 | 2025 | 361 | 4.450 |
Why?
| | Lyme Disease | 12 | 2024 | 31 | 3.750 |
Why?
| | Gene Expression Regulation, Bacterial | 20 | 2025 | 187 | 3.140 |
Why?
| | Borrelia | 2 | 2024 | 3 | 1.560 |
Why?
| | Relapsing Fever | 2 | 2024 | 3 | 1.560 |
Why?
| | Adhesins, Bacterial | 7 | 2015 | 28 | 1.160 |
Why?
| | Trans-Activators | 8 | 2009 | 135 | 1.000 |
Why?
| | Sigma Factor | 8 | 2024 | 17 | 0.950 |
Why?
| | Lipoproteins | 3 | 2020 | 42 | 0.830 |
Why?
| | Staphylococcus aureus | 10 | 2019 | 338 | 0.830 |
Why?
| | Bacterial Outer Membrane Proteins | 6 | 2008 | 20 | 0.780 |
Why?
| | Virulence Factors | 4 | 2025 | 80 | 0.700 |
Why?
| | Mutagenesis | 4 | 2018 | 61 | 0.670 |
Why?
| | Serine Endopeptidases | 2 | 2019 | 50 | 0.670 |
Why?
| | Mice | 16 | 2025 | 5949 | 0.650 |
Why?
| | Mutation | 9 | 2019 | 1347 | 0.650 |
Why?
| | Animal Diseases | 1 | 2019 | 3 | 0.650 |
Why?
| | Lac Repressors | 2 | 2018 | 3 | 0.650 |
Why?
| | Genetic Engineering | 1 | 2018 | 23 | 0.570 |
Why?
| | Animals | 19 | 2025 | 13505 | 0.530 |
Why?
| | Ixodes | 2 | 2008 | 6 | 0.530 |
Why?
| | DNA-Binding Proteins | 4 | 2016 | 422 | 0.510 |
Why?
| | Mice, Inbred C3H | 6 | 2024 | 83 | 0.500 |
Why?
| | Genetic Complementation Test | 5 | 2024 | 47 | 0.440 |
Why?
| | Microbial Viability | 2 | 2019 | 32 | 0.430 |
Why?
| | Lysine | 1 | 2014 | 89 | 0.430 |
Why?
| | Antigens, Bacterial | 4 | 2008 | 54 | 0.420 |
Why?
| | Arachnid Vectors | 2 | 2014 | 4 | 0.410 |
Why?
| | Genes, Essential | 2 | 2012 | 11 | 0.410 |
Why?
| | Repressor Proteins | 2 | 2007 | 155 | 0.390 |
Why?
| | Bites and Stings | 2 | 2008 | 20 | 0.350 |
Why?
| | Staphylococcal Infections | 5 | 2019 | 285 | 0.340 |
Why?
| | RNA Polymerase Sigma 54 | 5 | 2012 | 5 | 0.340 |
Why?
| | Transcription Factors | 4 | 2019 | 566 | 0.320 |
Why?
| | Plasmids | 4 | 2024 | 163 | 0.320 |
Why?
| | Needles | 1 | 2008 | 25 | 0.290 |
Why?
| | Luciferases | 1 | 2007 | 48 | 0.270 |
Why?
| | Genes, Reporter | 1 | 2007 | 88 | 0.270 |
Why?
| | Operon | 3 | 2019 | 27 | 0.250 |
Why?
| | DNA Mutational Analysis | 3 | 2016 | 180 | 0.250 |
Why?
| | Pore Forming Cytotoxic Proteins | 1 | 2025 | 11 | 0.250 |
Why?
| | Rats, Sprague-Dawley | 3 | 2020 | 1563 | 0.240 |
Why?
| | Yersinia pestis | 1 | 2025 | 19 | 0.240 |
Why?
| | Transcription, Genetic | 5 | 2008 | 378 | 0.230 |
Why?
| | Promoter Regions, Genetic | 5 | 2018 | 467 | 0.230 |
Why?
| | Gene Deletion | 4 | 2019 | 272 | 0.220 |
Why?
| | Green Fluorescent Proteins | 1 | 2024 | 93 | 0.220 |
Why?
| | Osteomyelitis | 2 | 2003 | 125 | 0.220 |
Why?
| | Genes, Bacterial | 5 | 2018 | 52 | 0.210 |
Why?
| | Arthritis, Infectious | 2 | 2003 | 43 | 0.210 |
Why?
| | Musculoskeletal Diseases | 1 | 2003 | 51 | 0.200 |
Why?
| | Disease Models, Animal | 5 | 2015 | 1478 | 0.190 |
Why?
| | Collagen | 2 | 2002 | 211 | 0.190 |
Why?
| | Spirochaetales | 1 | 2020 | 2 | 0.180 |
Why?
| | Recombinant Proteins | 2 | 2020 | 483 | 0.170 |
Why?
| | Ticks | 2 | 2014 | 6 | 0.170 |
Why?
| | Membrane Proteins | 2 | 2020 | 335 | 0.160 |
Why?
| | Female | 7 | 2024 | 28171 | 0.160 |
Why?
| | Leukocidins | 1 | 2019 | 7 | 0.160 |
Why?
| | Exotoxins | 1 | 2019 | 8 | 0.160 |
Why?
| | Mammals | 1 | 2019 | 61 | 0.160 |
Why?
| | Phagosomes | 1 | 2019 | 19 | 0.160 |
Why?
| | Body Temperature | 1 | 2019 | 78 | 0.160 |
Why?
| | DNA, Bacterial | 3 | 2016 | 176 | 0.160 |
Why?
| | Bacterial Toxins | 1 | 2019 | 51 | 0.150 |
Why?
| | Macrophages, Alveolar | 1 | 2019 | 30 | 0.150 |
Why?
| | Computational Biology | 1 | 2020 | 212 | 0.150 |
Why?
| | Genetic Vectors | 2 | 2018 | 128 | 0.150 |
Why?
| | Hot Temperature | 1 | 2019 | 214 | 0.150 |
Why?
| | Transformation, Bacterial | 1 | 2018 | 4 | 0.150 |
Why?
| | Electroporation | 1 | 2018 | 18 | 0.140 |
Why?
| | Gene Transfer Techniques | 1 | 2018 | 40 | 0.140 |
Why?
| | Stress, Physiological | 1 | 2019 | 183 | 0.140 |
Why?
| | Crystallography, X-Ray | 3 | 2014 | 156 | 0.140 |
Why?
| | Up-Regulation | 2 | 2018 | 454 | 0.140 |
Why?
| | Treponema pallidum | 2 | 2007 | 9 | 0.130 |
Why?
| | Rats | 2 | 2020 | 3220 | 0.130 |
Why?
| | Proteomics | 1 | 2019 | 329 | 0.130 |
Why?
| | Biofilms | 3 | 2015 | 191 | 0.120 |
Why?
| | DNA Replication | 1 | 2016 | 160 | 0.120 |
Why?
| | Humans | 10 | 2025 | 52483 | 0.120 |
Why?
| | Oxidative Stress | 1 | 2019 | 807 | 0.110 |
Why?
| | Protein Kinases | 1 | 2015 | 72 | 0.110 |
Why?
| | Point Mutation | 1 | 2014 | 67 | 0.110 |
Why?
| | Mutant Proteins | 1 | 2014 | 37 | 0.110 |
Why?
| | Amino Acid Substitution | 1 | 2014 | 82 | 0.110 |
Why?
| | Immune Evasion | 1 | 2014 | 15 | 0.110 |
Why?
| | Protein Conformation | 1 | 2014 | 176 | 0.110 |
Why?
| | Molecular Sequence Data | 4 | 2007 | 778 | 0.100 |
Why?
| | RNA, Bacterial | 4 | 2008 | 57 | 0.100 |
Why?
| | Protein Binding | 3 | 2009 | 667 | 0.100 |
Why?
| | Gene Expression Profiling | 4 | 2019 | 1105 | 0.090 |
Why?
| | Electrophoretic Mobility Shift Assay | 2 | 2009 | 74 | 0.090 |
Why?
| | Natural Killer T-Cells | 1 | 2010 | 5 | 0.090 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2010 | 54 | 0.080 |
Why?
| | Bacterial Vaccines | 1 | 2008 | 7 | 0.080 |
Why?
| | Antigens, Surface | 1 | 2008 | 47 | 0.080 |
Why?
| | Injections, Intradermal | 1 | 2008 | 14 | 0.070 |
Why?
| | Periplasmic Binding Proteins | 1 | 2007 | 2 | 0.070 |
Why?
| | Polyamines | 1 | 2007 | 8 | 0.070 |
Why?
| | Isopropyl Thiogalactoside | 1 | 2007 | 1 | 0.070 |
Why?
| | Fireflies | 1 | 2007 | 1 | 0.070 |
Why?
| | Genetic Techniques | 1 | 2007 | 15 | 0.070 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2010 | 582 | 0.070 |
Why?
| | Sequence Analysis, DNA | 1 | 2007 | 229 | 0.060 |
Why?
| | Virulence | 2 | 2005 | 167 | 0.060 |
Why?
| | Siphonaptera | 1 | 2025 | 2 | 0.060 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 2005 | 12 | 0.060 |
Why?
| | Plague | 1 | 2025 | 15 | 0.060 |
Why?
| | Carbon-Sulfur Lyases | 1 | 2004 | 2 | 0.060 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2006 | 95 | 0.060 |
Why?
| | Polymerase Chain Reaction | 2 | 2005 | 461 | 0.060 |
Why?
| | Open Reading Frames | 2 | 2006 | 55 | 0.060 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2004 | 70 | 0.060 |
Why?
| | Phosphorylation | 2 | 2016 | 528 | 0.060 |
Why?
| | Colony Count, Microbial | 2 | 2019 | 63 | 0.050 |
Why?
| | Adaptation, Physiological | 2 | 2019 | 110 | 0.050 |
Why?
| | Culture Media | 2 | 2019 | 98 | 0.050 |
Why?
| | Immunoblotting | 2 | 2015 | 116 | 0.050 |
Why?
| | RNA, Antisense | 1 | 2002 | 6 | 0.050 |
Why?
| | Lipase | 1 | 2002 | 11 | 0.050 |
Why?
| | Hemolysis | 1 | 2002 | 28 | 0.050 |
Why?
| | Hemolysin Proteins | 1 | 2002 | 15 | 0.050 |
Why?
| | Fibronectins | 1 | 2002 | 37 | 0.050 |
Why?
| | Staphylococcus | 1 | 2001 | 34 | 0.050 |
Why?
| | Binding Sites | 3 | 2006 | 377 | 0.040 |
Why?
| | Mice, Inbred BALB C | 2 | 2015 | 312 | 0.040 |
Why?
| | Carrier Proteins | 1 | 2002 | 313 | 0.040 |
Why?
| | DNA Primers | 3 | 2006 | 208 | 0.040 |
Why?
| | Base Sequence | 3 | 2006 | 640 | 0.040 |
Why?
| | Incidence | 1 | 2003 | 1062 | 0.040 |
Why?
| | Severity of Illness Index | 1 | 2003 | 1026 | 0.040 |
Why?
| | Guanosine Pentaphosphate | 1 | 2019 | 1 | 0.040 |
Why?
| | Guanosine Tetraphosphate | 1 | 2019 | 1 | 0.040 |
Why?
| | Regulon | 1 | 2019 | 7 | 0.040 |
Why?
| | Microarray Analysis | 1 | 2019 | 71 | 0.040 |
Why?
| | Anti-Bacterial Agents | 2 | 2019 | 807 | 0.040 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2008 | 178 | 0.030 |
Why?
| | Protein Structure, Tertiary | 2 | 2007 | 242 | 0.030 |
Why?
| | Luminescent Measurements | 1 | 2015 | 16 | 0.030 |
Why?
| | Models, Molecular | 2 | 2007 | 348 | 0.030 |
Why?
| | Cloning, Molecular | 2 | 2006 | 190 | 0.030 |
Why?
| | Lung | 1 | 2019 | 509 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2015 | 108 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 185 | 0.030 |
Why?
| | Ligands | 2 | 2006 | 206 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2008 | 1132 | 0.030 |
Why?
| | Interleukin-4 | 1 | 2010 | 44 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2010 | 57 | 0.020 |
Why?
| | Cell Separation | 1 | 2010 | 83 | 0.020 |
Why?
| | Lymphocyte Activation | 1 | 2010 | 172 | 0.020 |
Why?
| | Time Factors | 2 | 2006 | 2968 | 0.020 |
Why?
| | Genes, Regulator | 1 | 2008 | 5 | 0.020 |
Why?
| | Myxococcus xanthus | 1 | 2008 | 1 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2010 | 552 | 0.020 |
Why?
| | DNA, Complementary | 1 | 2008 | 135 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2008 | 140 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2010 | 478 | 0.020 |
Why?
| | Temperature | 1 | 2008 | 183 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2010 | 665 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2008 | 405 | 0.020 |
Why?
| | Calorimetry | 1 | 2006 | 6 | 0.020 |
Why?
| | Nucleosides | 1 | 2006 | 5 | 0.020 |
Why?
| | Histidine | 1 | 2006 | 15 | 0.020 |
Why?
| | Protein Structure, Secondary | 1 | 2006 | 71 | 0.020 |
Why?
| | Models, Chemical | 1 | 2006 | 66 | 0.020 |
Why?
| | Purines | 1 | 2006 | 34 | 0.020 |
Why?
| | Biological Transport | 1 | 2006 | 160 | 0.020 |
Why?
| | Cytoplasm | 1 | 2006 | 94 | 0.020 |
Why?
| | Restriction Mapping | 1 | 2005 | 33 | 0.020 |
Why?
| | Male | 2 | 2003 | 26761 | 0.020 |
Why?
| | Endopeptidase K | 1 | 2005 | 1 | 0.020 |
Why?
| | Sequence Deletion | 1 | 2005 | 73 | 0.010 |
Why?
| | Rabbits | 1 | 2006 | 375 | 0.010 |
Why?
| | RNA | 1 | 2006 | 168 | 0.010 |
Why?
| | Escherichia coli Proteins | 1 | 2005 | 55 | 0.010 |
Why?
| | Adenosine Triphosphate | 1 | 2006 | 205 | 0.010 |
Why?
| | Cell Membrane | 1 | 2006 | 245 | 0.010 |
Why?
| | Ethidium | 1 | 2004 | 6 | 0.010 |
Why?
| | Models, Genetic | 1 | 2005 | 169 | 0.010 |
Why?
| | Escherichia coli | 1 | 2006 | 192 | 0.010 |
Why?
| | Peptide Hydrolases | 1 | 2005 | 63 | 0.010 |
Why?
| | Ciprofloxacin | 1 | 2004 | 21 | 0.010 |
Why?
| | Plankton | 1 | 2004 | 6 | 0.010 |
Why?
| | Anaerobiosis | 1 | 2004 | 20 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 2005 | 160 | 0.010 |
Why?
| | Kinetics | 1 | 2006 | 626 | 0.010 |
Why?
| | Vancomycin | 1 | 2004 | 85 | 0.010 |
Why?
| | Catheterization | 1 | 2004 | 96 | 0.010 |
Why?
| | Consensus Sequence | 1 | 2003 | 22 | 0.010 |
Why?
| | Enhancer Elements, Genetic | 1 | 2003 | 58 | 0.010 |
Why?
| | Oligonucleotides | 1 | 2003 | 76 | 0.010 |
Why?
| | Down-Regulation | 1 | 2004 | 346 | 0.010 |
Why?
| | Proteins | 1 | 2006 | 348 | 0.010 |
Why?
| | Genes, rRNA | 1 | 2001 | 7 | 0.010 |
Why?
| | Blood | 1 | 2001 | 26 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2001 | 891 | 0.010 |
Why?
|
|
Blevins's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|